You have 9 free searches left this month | for more free features.

childhood mixed cellularity Hodgkin lymphoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Childhood Favorable Prognosis Hodgkin Lymphoma, Childhood Lymphocyte Depletion Hodgkin Lymphoma, Childhood Mixed Cellularity

Completed
  • Childhood Favorable Prognosis Hodgkin Lymphoma
  • +5 more
  • radiation therapy
  • +11 more
  • Arcadia, California
    Children's Oncology Group
Mar 26, 2021

Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

Completed
  • Adult Lymphocyte Depletion Hodgkin Lymphoma
  • +5 more
  • gemcitabine hydrochloride
  • bendamustine hydrochloride
  • Atlanta, Georgia
  • +1 more
Oct 21, 2021

Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

Active, not recruiting
  • Adult Lymphocyte Depletion Hodgkin Lymphoma
  • +16 more
  • 6,8-bis(benzylthio)octanoic acid
  • bendamustine hydrochloride
  • Winston-Salem, North Carolina
  • +1 more
Apr 8, 2022

Lymphoma, B-Cell Trial in Taipei (Short-Term Calorie Reduction)

Recruiting
  • Lymphoma, B-Cell
  • Short-Term Calorie Reduction
  • Taipei, Taiwan
    NTUH
May 18, 2022

Acute Lymphoblastic Leukemia, Hodgkin Disease, Allogeneic Stem Cell Transplantation Trial in Erlangen (Low-field magnetic

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Low-field magnetic resonance imaging
  • +3 more
  • Erlangen, Bavaria, Germany
    Department of Pediatrics and Adolescent Medicine
Oct 23, 2023

Childhood Non-Hodgkin Lymphoma, Childhood Acute Lymphoblastic Leukemia, Childhood Acute Myeloid Leukemia Trial in Oslo,

Recruiting
  • Childhood Non-Hodgkin Lymphoma
  • +2 more
  • Goal Management Training (GMT)
  • Brain Health Workshop (BHW)
  • Oslo, Norway
  • +2 more
May 25, 2022

Frailty in Young Adult Survivors of Childhood Cancer

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Jul 8, 2022

    ADLs at End of Acute Treatment for Childhood Leukemia and

    Enrolling by invitation
    • Childhood Cancer
    • Assessment of the accomplishment regarding Activities of Daily Living at the end of acute treatment
    • Munich, Germany
      Kinderklinik München Schwabing, TUM School of Medicine, Departme
    May 9, 2022

    Ann Arbor Stage I Hodgkin Lymphoma, Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma, Ann Arbor Stage I Nodular

    Recruiting
    • Ann Arbor Stage I Hodgkin Lymphoma
    • +13 more
    • Birmingham, Alabama
    • +16 more
    Nov 23, 2021

    Cognitive Impairment in Young Patients With Cancer Prospectively

    Recruiting
    • Chemotherapy-Related Cognitive Impairment
    • +9 more
      • Copenhagen, Denmark
        Rigshospitalet
      Apr 24, 2023

      ALL, Hodgkin Lymphoma, Cancer Trial in Memphis (Transcranial photobiomodulation (tPBM) - Mobile System)

      Not yet recruiting
      • ALL
      • +3 more
      • Transcranial photobiomodulation (tPBM) - Mobile System
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Dec 6, 2022

      Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

      Recruiting
      • Recurrent Childhood Acute Myeloid Leukemia
      • +17 more
        • Miami, Florida
          Nicklaus Children's Hospital
        May 13, 2023

        Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

        Active, not recruiting
        • Adult Grade III Lymphomatoid Granulomatosis
        • +23 more
        • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
        • +2 more
        • Duarte, California
          City of Hope Medical Center
        Jan 4, 2023

        AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell

        Completed
        • AIDS-related Diffuse Large Cell Lymphoma
        • +8 more
        • Eldoret, Kenya
        • +1 more
        Sep 12, 2022

        Ex Vivo Drug Sensitivity Testing and Mutation Profiling

        Completed
        • Recurrent Childhood Acute Myeloid Leukemia
        • +13 more
          • Miami, Florida
            Nicklaus Children's Hospital
          Jan 18, 2023

          Clinical, Laboratory and Epidemiologic Characterization of

          Recruiting
          • Waldenstrom Macroglobulinemia
          • +4 more
            • Bethesda, Maryland
            • +1 more
            Jan 25, 2023

            ALL, Childhood, Lymphoblastic Lymphoma, Childhood, Lymphoblastic Leukemia, Acute, Childhood Trial in Australia, United States

            Recruiting
            • ALL, Childhood
            • +2 more
            • Los Angeles, California
            • +17 more
            Aug 11, 2022

            Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-219)

            Recruiting
            • Acute Myeloid Leukemia
            • +12 more
            • Los Angeles, California
            • +6 more
            Jun 1, 2022

            Lymphoma, Childhood Lymphoma, Solid Tumor Trial in Charlottesville (Genistein, Placebo)

            Terminated
            • Lymphoma
            • +15 more
            • Charlottesville, Virginia
              University of Virginia
            Feb 8, 2022

            AML - Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome), Mixed Phenotype Acute Leukemia Trial in Palo Alto (T-allo10)

            Recruiting
            • AML - Acute Myeloid Leukemia
            • +5 more
            • T-allo10
            • Palo Alto, California
              Lucile Packard Children's Hospital
            Feb 2, 2022

            Pediatric Cancer, Hodgkin Disease, CD30-Positive DLBCL Trial in Milwaukee (anti-CD30 Bispecific Antibody-armed

            Not yet recruiting
            • Pediatric Cancer
            • +11 more
            • anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC)
            • Milwaukee, Wisconsin
              Children's Wisconsin
            Sep 14, 2022

            Childhood Cancer Trial in Munich (Exercise)

            Completed
            • Childhood Cancer
            • Exercise
            • Munich, Bavaria, Germany
              Kinderklinik München Schwabing TUM School of Medicine, Departmen
            May 26, 2021

            T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

            Recruiting
            • T-cell Lymphoma
            • +30 more
            • Optional Blood Sample
            • Optional Nail Sample
            • Duarte, California
            • +25 more
            Jul 28, 2023

            Late Effects, Testicular Germ Cell Tumor Mixed, Non-Metastatic Breast Carcinoma Trial in Lyon (PASCA intervention)

            Recruiting
            • Late Effects
            • +8 more
            • PASCA intervention
            • Lyon, France
              Centre Leon Berard
            Mar 15, 2022

            Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma

            Terminated
            • Adult Grade III Lymphomatoid Granulomatosis
            • +116 more
            • brentuximab vedotin
            • +2 more
            • Chicago, Illinois
            • +2 more
            Aug 30, 2021